BancorpSouth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$395K Sell
6,192
-715
-10% -$41.7K 0.04% 166
2017
Q2
$385K Buy
6,907
+698
+11% +$38K 0.04% 148
2017
Q1
$338K Hold
6,209
0.04% 157
2016
Q4
$363K Buy
+6,209
New +$339K 0.04% 141
2016
Q3
Sell
-3,442
Closed -$253K 250
2016
Q2
$253K Sell
3,442
-643
-16% -$45.4K 0.03% 180
2016
Q1
$261K Sell
4,085
-1
-0% -$63 0.03% 180
2015
Q4
$281K Buy
4,086
+693
+20% +$45.8K 0.03% 177
2015
Q3
$201K Hold
3,393
0.03% 213
2015
Q2
$226K Sell
3,393
-88
-3% -$5.8K 0.03% 210
2015
Q1
$225K Sell
3,481
-353
-9% -$22.1K 0.02% 214
2014
Q4
$226K Sell
3,834
-2,202
-36% -$124K 0.02% 227
2014
Q3
$309K Sell
6,036
-137
-2% -$6.84K 0.03% 183
2014
Q2
$299K Sell
6,173
-2,122
-26% -$105K 0.03% 185
2014
Q1
$431K Buy
8,295
+704
+9% +$37.5K 0.05% 165
2013
Q4
$404K Sell
7,591
-31
-0.4% -$1.58K 0.04% 160
2013
Q3
$352K Sell
7,622
-5,076
-40% -$223K 0.04% 161
2013
Q2
$568K Buy
+12,698
New +$551K 0.07% 111

Other funds holding BMY

BancorpSouth's BMY Position: Q3 2017 in Review

BancorpSouth reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2017, selling an estimated $41.7K and leaving 6,192 shares worth $395K. The position accounts for 0.04% of the portfolio, ranked #166.

BancorpSouth first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $568K in Q2 2013. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • BancorpSouth held 6,192 shares of Bristol-Myers Squibb worth $395K as of Q3 2017.
  • BancorpSouth sold 715 Bristol-Myers Squibb shares in Q3 2017, an estimated $41.7K.
  • Bristol-Myers Squibb made up 0.04% of BancorpSouth's portfolio in Q3 2017, its #166 holding.
  • BancorpSouth first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
  • BancorpSouth's Bristol-Myers Squibb position peaked at $568K in Q2 2013.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.